1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Amarin Corp PLC (AMRN)
  7. News

AMRN

Amarin News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Amarin Corp PLC AMRN NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 3.57 20:00:00
Open Price Low Price High Price Close Price Prev Close
3.595 3.49 3.62 3.58 3.57
more quote information »

Recent News

Date Time Source Heading
11/16/202110:52SEEKAmarin jumps after activist Sarissa discloses stake in 13-F..
11/16/202107:00GLOBEAmarin Reports Overview of Latest Clinical Research..
11/15/202116:30GLOBEAmarin Reports Subgroup Data from REDUCE-IT® Highlighting..
11/11/202107:00GLOBEAmarin to Present at Two Upcoming Investor Conferences
11/08/202107:00GLOBELatest Research Evaluating VASCEPA®/VAZKEPA (Icosapent..
11/03/202106:40SEEKAmarin shares fall after Q3 topline miss, cash position..
11/03/202106:03SEEKAmarin EPS beats by $0.01, misses on revenue
11/03/202106:00GLOBEAmarin Reports Third Quarter 2021 Financial Results and..
11/02/202111:36SEEKAmarin Q3 2021 Earnings Preview
10/20/202107:05GLOBEAmarin to Report Third Quarter 2021 Financial Results and..
10/12/202107:00IHNWCEO Presenting on the Emerging Growth Conference on October..
9/27/202108:31EDGARCurrent Report Filing (8-k)
9/22/202109:15GLOBEAmarin Outlines New Go-to-Market Strategy to Accelerate..
9/13/202107:00GLOBEAmarin Announces First European Launch of VAZKEPA (icosapent..
9/13/202106:00GLOBEAmarin to Participate in September Investment Conferences
8/31/202107:00GLOBEAmarin Reports Overview of Latest Clinical Research..
8/30/202107:00IHNWCEO Presenting on the Emerging Growth Conference on..
8/23/202103:15GLOBEAmarin Reports Data from REDUCE-IT® Showing VASCEPA®/VAZKEPA..
8/17/202107:00IHNWCEO Presenting on the Emerging Growth Conference on..
8/16/202107:00GLOBELatest Clinical Research Evaluating VASCEPA®/VAZKEPA..
8/16/202106:55SEEKHLS Therapeutics inks promotional agreement with Pfizer for..
8/05/202109:58TRMNAmarin Q2 Earnings, Revenues Surpass Estimates
8/05/202107:58SEEKAmarin posts Q2 earnings beat, provides cash position update
8/05/202106:09EDGARCurrent Report Filing (8-k)
8/05/202106:03SEEKAmarin EPS beats by $0.06, beats on revenue
8/05/202106:00GLOBEAmarin Reports Second Quarter and Six Month 2021 Financial..
8/02/202108:27IHNWCEO Presenting on the Emerging Growth Conference on August..
7/15/202106:35GLOBEAmarin to Report Second Quarter and Six Month 2021 Financial..
7/06/202107:00IHNWCEO Presenting on the Emerging Growth / Investors Hub Joint..
6/30/202107:30IHNWSino United (OTC Pink: SUIC) $200 Million Commitment, Signs..
6/22/202107:00IHNWCEO Presenting on the First Emerging Growth / Investors Hub..
6/21/202109:41SEEKAmarin falls after Supreme Court rejection on Vascepa
6/15/202108:41EDGARCurrent Report Filing (8-k)
6/08/202107:00IHNWCEO's Presenting at Emerging Growth Conference Virtually..
6/02/202116:30GLOBEFurther Insights into Mechanism of Action of Icosapent Ethyl..
5/25/202107:00IHNWCEO's Presenting at Emerging Growth Conference Virtually..
5/18/202106:05GLOBEAmarin to Present at Two Investor Conferences in June 2021
5/17/202116:05GLOBEAmarin Highlights Multiple Scientific Findings for VASCEPA®..
5/15/202108:00GLOBEREDUCE-IT® Heart Failure Analyses by VASCEPA® (Icosapent..
5/04/202107:00GLOBEClinical Data and Other Research Results Regarding VASCEPA®..
4/29/202107:31SEEKAmarin reports decline in Q1 revenue ahead of European..
4/29/202106:36EDGARQuarterly Report (10-q)
4/29/202106:16SEEKAmarin EPS beats by $0.07, misses on revenue
4/29/202106:10GLOBEAmarin Reports First Quarter 2021 Financial Results and..
4/29/202106:00GLOBEAmarin Announces Planned Retirement of Joseph T. Kennedy,..
4/28/202113:06SEEKAmarin Q1 2021 Earnings Preview
4/22/202111:22SEEKUK approves Amarin's Vazkepa for cardiovascular risk..
4/22/202110:53GLOBEAmarin Receives Great Britain Marketing Authorization for..
4/20/202106:05GLOBEAmarin to Report First Quarter Results and Host Conference..
4/17/202109:50GLOBEVASCEPA® (Icosapent Ethyl) Reported to Impact Vulnerable..
See more news about this stock »


Your Recent History
NASDAQ
AMRN
Amarin
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.